Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-02 @ 10:50 AM
Study NCT ID:
NCT05940532
Status:
RECRUITING
Last Update Posted:
2023-07-11
First Post:
2023-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Sponsor:
Hunan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HTOSG Lung 001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None